195例重症COVID-19患者的临床病程:一项回顾性多中心研究
该回顾性多中心研究分析了2020年1月5日至4月3日中国湖北省195例重症COVID-19患者,收集流行病学、临床特征、治疗和结局数据。92.8%患者接受通气支持,其中43.1%无创、49.7%有创机械通气;ARDS病程中可见早期低氧血症、后续高碳酸血症、肺动脉高压及肺纤维化。45.6%出现休克,急性肾损伤29.7%,继发感染28.2%。28天总死亡率42.1%,ICU死亡率约33%,低PaO2/FiO2比值是死亡的独立危险因素,多数非幸存者病毒载量高。
要点
- 195例重症COVID-19患者28天总死亡率为42.1%,ICU死亡率约33%,16例在入ICU前死亡。
- 92.8%接受通气支持,其中无创通气43.1%、有创机械通气49.7%;有创通气者中28.9%接受俯卧位通气、58.8%接受神经肌肉阻滞治疗。
- 45.6%出现休克,急性肾损伤29.7%,继发感染28.2%。
- 低PaO2/FiO2比值是死亡的独立危险因素,多数非幸存者病毒载量高。
- ARDS病程中可见早期低氧血症、后续高碳酸血症、肺动脉高压及肺纤维化。
适用人群与场景
- 2020年1月5日至4月3日中国湖北省195例重症COVID-19患者。
处置流程与药物剂量
- 通气支持:181例(92.8%)接受通气支持,84例(43.1%)无创通气,97例(49.7%)有创机械通气。
- 有创机械通气者中28例(28.9%)接受俯卧位通气,57例(58.8%)接受神经肌肉阻滞治疗,22例(11.3%)因长期使用呼吸机行气管切开。
- 血流动力学支持为重症监护的基石之一。
研究设计与关键结果
- 回顾性多中心研究,纳入195例重症COVID-19患者,收集流行病学、临床特征、治疗和结局数据。
- 大多数重症患者年龄较大且急性生理与慢性健康评估II评分较高。
- 181例(92.8%)接受通气支持,其中84例(43.1%)无创通气、97例(49.7%)有创机械通气;97例有创机械通气者中28例(28.9%)接受俯卧位通气、57例(58.8%)接受神经肌肉阻滞治疗、22例(11.3%)因长期使用呼吸机行气管切开。
- ARDS病程中可见早期低氧血症、后续高碳酸血症、肺动脉高压及最终肺纤维化。
- 89例(45.6%)出现休克,急性肾损伤占29.7%,继发感染占28.2%。
- 28天总死亡率为42.1%,ICU死亡率约33%,16例在入ICU前死亡。
- 低PaO2/FiO2比值是死亡的独立危险因素,多数非幸存者病毒载量高。
证据类型、等级与局限
- 证据类型:回顾性多中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为ARDS和休克是COVID-19重症期的突出表现,通气支持和血流动力学支持是重症监护的基石。
- 作者认为高病毒载量与重症COVID-19患者死亡相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Coronavirus disease-2019 (COVID-19) outbreak has spread around the world. However, the dynamic course of critically ill COVID-19 has not been described thoroughly.
PATIENTS AND METHODS: We retrospectively analyzed 195 critically ill COVID-19 patients in Hubei province, China, between January 5, 2020 and April 3, 2020. Epidemiologic data, clinical features, treatments, and outcomes were collected and analyzed.
RESULTS: Most critically ill patients were older with higher Acute Physiology and Chronic Health Evaluation II scores. After critical illness onset, a total of 181 (92.8%) patients received ventilation support, of which 84 (43.1%) received noninvasive and 97 (49.7%) received invasive mechanic ventilation (IMV). Among the 97 patients with IMV, 28 (28.9%) received prone ventilation, 57 (58.8%) received neuromuscular blocked therapy, and 22 (11.3%) received tracheostomy due to prolonged ventilator use. Early hypoxemia, subsequent hypercapnia, pulmonary hypertension, and finally pulmonary fibrosis were notable in the clinical course of acute respiratory distress syndrome (ARDS). Eighty-nine (45.6%) patients presented with shock. Acute kidney injury (29.7%) and secondary infection (28.2%) were also notable. The overall mortality of critically ill patients at day 28 was 42.1%. Intensive care unit (ICU) mortality was around 33%, as 16 patients died prior to ICU admission. A low PaO2/FiO2 ratio was an independent risk factor for death. High viral load was observed in most non-survivors.
CONCLUSION: ARDS and shock were notable in the critical illness of COVID-19. Ventilation support and hemodynamic support were the cornerstones for critical care. High viral load was associated with death of critically ill COVID-19 patients.
参考来源
- Zhou S, Yang Y, Zhang X, et al. Clinical Course of 195 Critically Ill COVID-19 Patients: A Retrospective Multicenter Study. Shock. 2020. PMID: 32826818. doi:10.1097/SHK.0000000000001629
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。